Jul 5, 2022
Dr. Jennifer Jones-McMeans is a Divisional Vice President of Global Clinical Affairs at Abbott Vascular Business and she sheds light on the FDA guidance to encourage sponsors of clinical trials to include all genders, ethnicities, and under-represented patients to participate. New guidelines are more organized and...
Jul 5, 2022
Dr. Jennifer Jones-McMeans is a Divisional Vice President of Global Clinical Affairs at Abbott Vascular Business and she sheds light on the FDA guidance to encourage sponsors of clinical trials to include all genders, ethnicities, and under-represented patients to participate. New guidelines are more organized and...
Feb 21, 2022
Scott Gray is the President and CEO of Clincierge with a mission to support participants in clinical trials, particularly for patients with rare diseases. Since many rare diseases require a patient caregiver to accompany a trial participant, Clincierge also manages the logistics for both of those people. The result of...
Feb 21, 2022
Scott Gray is the President and CEO of Clincierge with a mission to support participants in clinical trials, particularly for patients with rare diseases. Since many rare diseases require a patient caregiver to accompany a trial participant, Clincierge also manages the logistics for both of those people. The result of...
Jan 18, 2022
Tom Lemberg is the Founder and CEO of Curebase and was recently included in the Forbes 30 under 30 list for 2022 for leading positive global change in healthcare. Curebase is shaking up the world of clinical trials by providing software for patients making it easy for them to participate from home, software for doctors...